This Article Full Text Full Text (PDF) All Versions of this Article: 91/7/2569    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Jong, F. J. Articles by Breteler, M. M. B. Search for Related Content PubMed PubMed Citation Articles by de Jong, F. J. Articles by Breteler, M. M. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Dementia Hazardous Substances DB LEVOTHYROXINE LIOTHYRONINE Related Collections Neuroendocrinology and Pituitary Thyroid

Thyroid Hormones, Dementia, and Atrophy of the Medial Temporal Lobe

Departments of Epidemiology and Biostatistics (F.J.d.J., T.d.H., A.H., M.M.B.B.), Neurology (F.J.d.J., T.d.H.), Internal Medicine (T.J.V., Y.B.d.R.), and Immunology (H.A.D.), Erasmus Medical Center, 3000 DR Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: Dr. Monique M. B. Breteler, Department of Epidemiology and Biostatistics, Erasmus Medical Center, 3000 DR Rotterdam, The Netherlands. E-mail: m.breteler{at}erasmusmc.nl.

Context: Thyroid function has been related to Alzheimer disease (AD), but it remains unclear whether thyroid dysfunction results from or contributes to developing AD.

Objective: The objective of the study was to determine the association between thyroid function and both medial temporal lobe atrophy on brain magnetic resonance imaging (MRI) as putative early sign of AD and risk of dementia.

Design and Participants: This was a population-based cohort study among 1077 elderly subjects aged 60–90 yr and dementia free at baseline (1995–1996).

Main Outcome Measures: Nonfasting serum levels of TSH, free T₄ (fT₄), T₃, and rT₃ were available in 1025 subjects followed up for incident dementia until 2005. In a subset of 489 nondemented elderly, we assessed volumes of the hippocampus and amygdala on brain MRI. Subjects using thyroid medication were excluded.

Results: During 5657 person-years of follow-up (mean 5.5 yr), 63 subjects were diagnosed with dementia (46 with AD). TSH and thyroid hormones were not associated with risk of dementia or AD. TSH and T₃ were also not related to brain atrophy, whereas nondemented subjects with higher fT₄ levels had more hippocampal and amygdalar atrophy on MRI. Similar associations were found for rT₃. Excluding subjects with thyroid disorders or incipient AD did not change the results.

Conclusion: In our study, TSH was related neither to risk of AD nor with early MRI markers thereof, arguing against an important role of thyroid function in the development of AD. Whether the association of higher fT₄ and rT₃ levels with brain atrophy on MRI has functional significance remains to be elucidated.

This article has been cited by other articles:

				B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]

				F. J. de Jong, R. P. Peeters, T. den Heijer, W. M. van der Deure, A. Hofman, A. G. Uitterlinden, T. J. Visser, and M. M. B. Breteler The Association of Polymorphisms in the Type 1 and 2 Deiodinase Genes with Circulating Thyroid Hormone Parameters and Atrophy of the Medial Temporal Lobe J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 636 - 640. [Abstract] [Full Text] [PDF]